Search This Blog

Thursday, January 4, 2024

Innate Pharma: FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program

 

  • FDA lifts partial clinical hold on lacutamab clinical program
  • Fatal case related to disease progression and unrelated to the treatment
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)